| Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity M Soethoudt, U Grether, J Fingerle, TW Grim, F Fezza, L De Petrocellis, ... Nature communications 8 (1), 13958, 2017 | 340 | 2017 |
| Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and … SD Banister, M Longworth, R Kevin, S Sachdev, M Santiago, J Stuart, ... ACS Chemical Neuroscience 7 (9), 1241-1254, 2016 | 269 | 2016 |
| Pharmacology of indole and indazole synthetic cannabinoid designer drugs ab-fubinaca, adb-fubinaca, ab-pinaca, adb-pinaca, 5f-ab-pinaca, 5f-adb-pinaca, adbica, and 5f-adbica SD Banister, M Moir, J Stuart, RC Kevin, KE Wood, M Longworth, ... ACS chemical neuroscience 6 (9), 1546-1559, 2015 | 251 | 2015 |
| Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135 SD Banister, J Stuart, RC Kevin, A Edington, M Longworth, SM Wilkinson, ... ACS Chemical Neuroscience 6 (8), 1445-1458, 2015 | 225 | 2015 |
| The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways HB Bradshaw, N Rimmerman, SSJ Hu, VM Benton, JM Stuart, K Masuda, ... BMC biochemistry 10, 1-11, 2009 | 147 | 2009 |
| Novel endogenous N-acyl amides activate TRPV1-4 receptors, BV-2 microglia, and are regulated in brain in an acute model of inflammation S Raboune, JM Stuart, E Leishman, SM Takacs, B Rhodes, A Basnet, ... Frontiers in cellular neuroscience 8, 195, 2014 | 120 | 2014 |
| The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse SD Banister, SM Wilkinson, M Longworth, J Stuart, N Apetz, K English, ... ACS chemical neuroscience 4 (7), 1081-1092, 2013 | 102 | 2013 |
| Targeted lipidomics in Drosophila melanogaster identifies novel 2-monoacylglycerols and N-acyl amides G Tortoriello, BP Rhodes, SM Takacs, JM Stuart, A Basnet, S Raboune, ... PloS one 8 (7), e67865, 2013 | 89 | 2013 |
| Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass R Smoum, A Bar, B Tan, G Milman, M Attar-Namdar, O Ofek, JM Stuart, ... Proceedings of the National Academy of Sciences 107 (41), 17710-17715, 2010 | 81 | 2010 |
| Composition and use of cannabis extracts for childhood epilepsy in the Australian community A Suraev, N Lintzeris, J Stuart, RC Kevin, R Blackburn, E Richards, ... Scientific reports 8 (1), 10154, 2018 | 77 | 2018 |
| Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding J Russell, S Maguire, GE Hunt, A Kesby, A Suraev, J Stuart, J Booth, ... Psychoneuroendocrinology 87, 83-92, 2018 | 77 | 2018 |
| Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides J Fichna, M Sałaga, J Stuart, D Saur, M Sobczak, H Zatorski, ... Neurogastroenterology & Motility 26 (4), 470-481, 2014 | 60 | 2014 |
| Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels M Heblinski, M Santiago, C Fletcher, J Stuart, M Connor, IS McGregor, ... Cannabis and cannabinoid research 5 (4), 305-317, 2020 | 57 | 2020 |
| ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice N Brzozowska, KM Li, XS Wang, J Booth, J Stuart, IS McGregor, JC Arnold PeerJ 4, e2081, 2016 | 52 | 2016 |
| Detection of Δ9 THC in oral fluid following vaporized cannabis with varied cannabidiol (CBD) content: An evaluation of two point‐of‐collection testing devices TR Arkell, RC Kevin, J Stuart, N Lintzeris, PS Haber, JG Ramaekers, ... Drug testing and analysis 11 (10), 1486-1497, 2019 | 48 | 2019 |
| Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA RC Kevin, KE Wood, J Stuart, AJ Mitchell, M Moir, SD Banister, M Kassiou, ... Journal of Psychopharmacology 31 (6), 757-769, 2017 | 35 | 2017 |
| Structure–activity relationships of synthetic cannabinoid designer drug RCS-4 and its regioisomers and C4 homologues SD Banister, J Stuart, T Conroy, M Longworth, M Manohar, C Beinat, ... Forensic Toxicology 33, 355-366, 2015 | 34 | 2015 |
| Identification of N‐arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors WJ Redmond, EE Cawston, NL Grimsey, J Stuart, AR Edington, M Glass, ... British Journal of Pharmacology 173 (1), 115-127, 2016 | 33 | 2016 |
| Endocannabinoid dysregulation in cognitive and stress-related brain regions in the Nrg1 mouse model of schizophrenia DJ Clarke, J Stuart, IS McGregor, JC Arnold Progress in Neuro-Psychopharmacology and Biological Psychiatry 72, 9-15, 2017 | 32 | 2017 |
| Brain levels of prostaglandins, endocannabinoids, and related lipids are affected by mating strategies JM Stuart, JJ Paris, C Frye, HB Bradshaw International journal of endocrinology 2013 (1), 436252, 2013 | 32 | 2013 |